The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/1592537

Int. J. Cancer 1992 May 28 51 3 470-5

Download in:

View as

General Info

PMID
1592537